EPIX - ESSA Pharma Inc.
IEX Last Trade
1.61
-0.010 -0.621%
Share volume: 1,362
Last Updated: Thu 26 Dec 2024 08:28:44 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$1.62
-0.01
-0.62%
Summary score
27%
Profitability
27%
Dept financing
13%
Liquidity
50%
Performance
25%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 31-Dec-2015 - 31-Dec-2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
3.22%
Return on assets
-28.4%
Return on sales
0%
Return on invested capital
119.85%
Total debt ratio
89.6%
Debt ratio change over timeo
-0.42%
Current Ratio
6.51%
Quick Ratio
0%
Cash Position Ratio
6.16%
Short-term ratios 31-Dec-2018 - 31-Dec-2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
-159.82%
Return on assets
-24.29%
Return on sales
0%
Return on invested capital
242.66%
Total debt ratio
41.54%
Debt ratio change over timeo
-0.54%
Current Ratio
12.82%
Quick Ratio
0%
Cash Position Ratio
12.55%
Last quarter ratios 31-Dec-2019
The data are presented for the financials results of the last quarter.
Return on equity
-10.04%
Return on assets
-9.99%
Return on sales
0%
Return on invested capital
744.3%
Total debt ratio
2.82%
Debt ratio change over time
-0.86%
Current Ratio
38.04%
Quick Ratio
0%
Cash Position Ratio
37.37%
Performance ratios (change over 4 years) 31-Dec-2015 - 31-Dec-2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-139.77%
Return on assets
-122.48%
Return on sales
0%
Return on invested capital
206.4%
Total debt ratio
-42.44%
Debt ratio change over time
-0.42%
Current Ratio
16.03%
Quick Ratio
0%
Cash Position Ratio
16.45%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | EPIX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | 3.22% | 3.38% | 10.1% | 6.09% |
| Return on assets | -28.4% | 3.79% | 3.51% | 5.38% |
| Return on sales | 0% | 33.46% | 42.92% | 33.01% |
| Return on invested capital | 119.85% | 4.88% | 8.3% | 11.96% |
| Profitability | 33% | 46% | 68% | 62% |
| Total debt ratio | 89.6% | 100.22% | 71.21% | 29.5% |
| Debt ratio change over time | -0.42% | 14.95% | 5.12% | 1.7% |
| Dept financing | 22% | 50% | 26% | 10% |
| Current Ratio | 12.82% | 1.56% | 2.5% | 4.04% |
| Quick Ratio | 0% | 1.45% | 2.22% | 3.29% |
| Cash Position Ratio | 12.55% | 0.97% | 0.66% | 1.72% |
| Liquididy | 50% | 17% | 42% | 41% |
| Short-term ratios | EPIX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -159.82% | -24.18% | 18.55% | 5.09% |
| Return on assets | -24.29% | 4.92% | 3.95% | 4% |
| Return on sales | 0% | 37.6% | 41.32% | 27.89% |
| Return on invested capital | 242.66% | 7.93% | 10.38% | 10.86% |
| Profitability | 25% | 49% | 71% | 45% |
| Total debt ratio | 41.54% | 112.95% | 82.58% | 25.55% |
| Debt ratio change over time | -0.54% | 16.62% | 5.88% | 2.04% |
| Dept financing | 9% | 50% | 27% | 9% |
| Current Ratio | 12.82% | 1.56% | 2.5% | 4.04% |
| Quick Ratio | 0% | 1.45% | 2.22% | 3.29% |
| Cash Position Ratio | 12.55% | 0.97% | 0.66% | 1.72% |
| Liquididy | 50% | 16% | 23% | 36% |